Instrument Inactif

Communiqués Endo, Inc.

Actions

NDOI

US29290D1173

Produits pharmaceutiques

Communiqués

24/07/25	Endo Presents Plantar Fibromatosis and Plantar Fasciitis Data at the American Podiatric Medical Association Annual Meeting	PR
17/07/25	Mallinckrodt Receives Necessary Ruling from Irish High Court to Combine with Endo, Inc.	PR
17/06/25	Endo Completes International Pharmaceuticals Business Divestiture	PR
16/06/25	Mallinckrodt And Endo Shareholders Approve Combination To Create A Global Scaled Diversified Pharmaceuticals Leader	AQ
13/06/25	Mallinckrodt and Endo Shareholders Approve Combination to Create a Global, Scaled, Diversified Pharmaceuticals Leader	PR
02/06/25	Endo Champions Men's Health Month with Education, Awareness, and Outreach	PR
16/05/25	ENDO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Endo, Inc. - NDOI	BU
15/05/25	Endo Expands ADRENALIN® Ready-to-Use Premixed Bag Line with New Concentration	PR
07/05/25	Endo : Q1 2025 Prepared Remarks	PU
28/04/25	Endo : Combining with Mallinckrodt Form of Voting Agreement	PU
24/04/25	Endo's New Spatial Computing Injection Simulator for Peyronie's Disease Creates Immersive Learning Environment for Urology Specialists	AQ
07/04/25	Endo to Report First Quarter 2025 Financial Results on May 7, 2025	AQ
24/03/25	Endo Presents Dupuytren Contracture Data at the IFSSH and IFSHT Triennial Congress	PR
18/03/25	Fitch Upgrades Mallinckrodt's IDR to 'B+'; Places Ratings on Positive Watch	AQ
14/03/25	ENDO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Endo, Inc. - NDOI	BU
13/03/25	Mallinckrodt to take over Endo in deal valued at $6.7 billion	AQ
13/03/25	Endo : Q4 2024 Press Release	PU
13/03/25	Endo : Q4 2024 Presentation	PU
13/03/25	Endo Reports Fourth-Quarter and Full-Year 2024 Financial Results	PR
11/03/25	Endo Announces Divestiture of International Pharmaceuticals Business	AQ
11/03/25	Endo Announces Divestiture of International Pharmaceuticals Business	PR
10/03/25	Endo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call	AQ
27/02/25	Endo Presents Healthcare Provider Survey at Joint Meeting of International Society for the Study of Women's Sexual Health (ISSWSH) and International Society for Sexual Medicine (ISSM)	PR
24/02/25	Endo to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025	AQ
21/02/25	Endo to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025	AQ